Despite the initial negative repercussions of the COVID-19 pandemic, aesthetic injectable procedures have rebounded in the US and will continue to expand through 2031. Demand for aesthetic injectables will be spurred by the launch of numerous new products and expanded indications, as well as a growing patient pool, including nontraditional patient groups such as men and younger individuals.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aesthetic injectables in the US from 2019 through 2031.
The COVID-19 pandemic has had both short- and long-term impacts on the aesthetic injectable market.
- What impact has the COVID-19 pandemic had on the US aesthetic injectable market?
- What new trends have emerged as a result of the pandemic?
- At what pace is the market recovering?
Both major players and newer entrants are developing new and improved aesthetic injectable offerings, as well as seeking expanded indications for these products.
- What trends are being seen in the market that are driving product innovations and improvements?
- What kinds of products are being developed by competitors? When are they expected to be launched?
- What product strategies are being employed by leaders in the aesthetic injectable space to remain competitive?
Mergers, acquisitions, and partnerships remain popular in the aesthetic injectable space.
- What are the most notable M&As in this market and what competitive advantages have they provided to the companies involved?
- Which companies have formed partnerships to develop products and expand their market presence? How have these agreements benefitted these competitors?
- What are the strategies adopted by companies to bolster their presence in the US?
Table of Contents
United States
Abstract
Executive Summary
- COVID-19 Updates
- Market Highlights
- Competitive Highlights
- Market Developments
- Procedures Covered
- Products Covered
Key Report Updates
COVID-19 Analysis
- Market Impact
- Major Market Forecast Changes and Assumptions
- Competitive Impact
Aesthetic Injectable Market
- Market Highlights
- Market Definitions
- Common Aesthetic Injectable Brands
- Market Forecast Data
- Competitive Insights
- Allergan (an AbbVie company)
- Galderma
- Other Key Competitors
- Factors Affecting All Competitors
- Market Shares
- Market Developments
Botulinum Toxin Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Insights
- US Botulinum Toxin Market Competitive Insights
- Factors Affecting All Competitors
- Market Shares
Dermal Filler Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Insights
- US Dermal Filler Market Competitive Insights
- Factors Affecting All Competitors
- Market Shares
Appendix
- Abbreviations
- Bibliography
Methodology
- Core Country Coverage Methodology
- Research Methodology
- Marketrack Methodology
- PriceTrack Methodology
- Forecast Methodology
- Supplemental Country Coverage Methodology
- Base-Year Ratio Analysis
- Market Forecasting
Tables and Figures
- Aesthetic Injectable Market, by Product Type, US (USD), 2019-2031
- Aesthetic Injectable Market Landscape, US (USD), 2021 and 2031
- Aesthetic Injectable Revenue Market Share Rankings, by Product Type, US, 2021
- Competitive Insights
- Companies Mentioned
- Recent Events in the Aesthetic Injectable Market, US
- Key Clinical Trials in the Aesthetic Injectable Market, US
- Emerging Products for the Aesthetic Injectable Market, US
- Aesthetic Injectable Procedures Covered, US
- Aesthetic Injectables Products Covered, US
- Common Aesthetic Injectable Brands
- COVID-19 Impact Assessment Summary, Aesthetic Injectable Market, US
- Aesthetic Injectable Market, by Product Type, US (USD), 2019-2031 (Excluding COVID-19 Impact)
- Aesthetic Injectable Market, by Product Type, US (USD), 2019-2031 (Including COVID-19 Impact)
- COVID-19 Competitive Factors and Strategies, Aesthetic Injectable Market, US
- COVID-19 Financial Impact and Competitor Insights
- US Aesthetic Injectable Market Drivers
- US Aesthetic Injectable Market Limiters
- Aesthetic Injectable Market, by Product Type, US (USD), 2019-2031
- Common Aesthetic Injectable Brands
- Aesthetic Injectable Procedures, by Product Type, US, 2019-2031
- Other Aesthetic Injectable Procedures, by Product Type, US, 2019-2031
- Aesthetic Injectable Market, by Product Type, US (USD), 2019-2031
- Other Aesthetic Injectable Market, US (USD), 2019-2031
- Allergan (an AbbVie company) Competitive Insights
- Galderma Competitive Insights
- Competitive Insights for Other Key Competitors
- Factors Affecting All Competitors
- Aesthetic Injectable Revenue Market Shares, US, 2021
- Aesthetic Injectable Revenue Market Shares, by Product Type, US, 2021
- Recent Events in the Aesthetic Injectable Market, US
- Key Clinical Trials in the Aesthetic Injectable Market, US
- Emerging Products for the Aesthetic Injectable Market, US
- US Botulinum Toxin Market Drivers
- US Botulinum Toxin Market Limiters
- BTX Market, US (USD), 2019-2031
- Volume of BTX Product per Procedure, by Product Type
- BTX Market, US (USD), 2019-2031
- US Botulinum Toxin Market Competitive Insights
- Factors Affecting All Competitors
- BTX Revenue Market Shares, US, 2021
- BTX Revenue Market Shares, US, 2021
- US Dermal Filler Market Drivers
- US Dermal Filler Market Limiters
- Dermal Filler Market, by Material, US (USD), 2019-2031
- Volume of Dermal Filler Product per Procedure, by Product Type
- Dermal Filler Procedures, by Material, US, 2019-2031
- Dermal Filler Market, by Material, US (USD), 2019-2031
- Dermal Filler Market Growth, by Material, US, 2020-2031
- US Dermal Filler Market Competitive Insights
- Factors Affecting All Competitors
- Dermal Filler Revenue Market Shares, US, 2021
- Dermal Filler Revenue Market Shares, by Material, US, 2021
- Abbreviations